PHARMACEUTICAL BLENDERS MARKET ANALYSIS

Regional Analysis

Pharmaceutical Blenders Market - Regional Analysis

On the basis of the region, the global pharmaceutical blenders market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America pharmaceutical blender market owes dominant position in the global market over the forecast period, owing to rapid growth in pharmaceutical industries in the region.

According to the International Trade Administration 2016, the U.S. is a major hub for drug manufacturing, as imports account only for around a quarter of the market by value. The manufacturing market in the U.S. is witnessing significant growth, which is expected to fuel growth of the pharmaceutical blenders market over the forecast period.

However, Asia Pacific pharmaceutical blenders market is expected to witness high CAGR over the forecast period, owing to emerging generic drug manufacturers in economies such as India and China. Moreover, favorable government schemes propel growth of pharmaceutical companies in the region, thereby driving growth of the market.

For instance, under the ‘Pharma Vision 2020’, the Government of India reduced the approval time for new facilities to propel investments for drug manufacturers in this region. Such initiatives are expected to attract foreign investors for the development of new manufacturing units, in turn increasing the demand for pharmaceutical blenders and further driving growth of the market.